Page results
- 
                                    
                                                                            This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump. 
- 
                                    
                                                                            The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022. 
- 
                                    
                                                                            Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies. 
- 
                                    
                                                                            RESPOND – Information for healthcare professionals and services working with asylum seekers 
- 
                                    
                                                                            The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia. 
- 
                                    
                                                                            UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo. 
- 
                                    
                                                                            Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future. 
- 
                                    
                                                                            People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH. 
- 
                                    
                                                                            Trial of T-cell therapy for lung cancer begins at UCLH 
- 
                                    
                                                                            Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.